VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 110 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,653 | +1213.1% | 2,003 | +1903.0% | 0.00% | – |
| Q2 2023 | $659 | -2.9% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $679 | -96.2% | 100 | -93.8% | 0.00% | – |
| Q1 2022 | $18,000 | -91.7% | 1,624 | -88.3% | 0.00% | – |
| Q4 2021 | $218,000 | +581.2% | 13,880 | +653.1% | 0.00% | – |
| Q3 2021 | $32,000 | -87.8% | 1,843 | -84.9% | 0.00% | – |
| Q2 2021 | $262,000 | +2520.0% | 12,167 | +1813.1% | 0.00% | – |
| Q1 2021 | $10,000 | -78.3% | 636 | -81.9% | 0.00% | – |
| Q4 2020 | $46,000 | -11.5% | 3,522 | -34.8% | 0.00% | – |
| Q3 2020 | $52,000 | +5100.0% | 5,404 | +5096.2% | 0.00% | – |
| Q2 2020 | $1,000 | -91.7% | 104 | -85.9% | 0.00% | – |
| Q4 2019 | $12,000 | +50.0% | 740 | +19.4% | 0.00% | – |
| Q3 2019 | $8,000 | -95.2% | 620 | -91.5% | 0.00% | -100.0% |
| Q3 2018 | $168,000 | +354.1% | 7,331 | +197.9% | 0.00% | – |
| Q4 2017 | $37,000 | -63.0% | 2,461 | -60.7% | 0.00% | -100.0% |
| Q4 2016 | $100,000 | -90.4% | 6,255 | -90.0% | 0.00% | -90.9% |
| Q3 2016 | $1,045,000 | +1641.7% | 62,772 | +777.9% | 0.01% | +1000.0% |
| Q1 2016 | $60,000 | -75.0% | 7,150 | -72.3% | 0.00% | -66.7% |
| Q4 2015 | $240,000 | -57.7% | 25,818 | -48.6% | 0.00% | -62.5% |
| Q3 2015 | $567,000 | +51.6% | 50,236 | +70.5% | 0.01% | +60.0% |
| Q2 2015 | $374,000 | -24.6% | 29,468 | -44.8% | 0.01% | -37.5% |
| Q1 2015 | $496,000 | -40.8% | 53,348 | -8.9% | 0.01% | -38.5% |
| Q4 2014 | $838,000 | +91.8% | 58,544 | +39.2% | 0.01% | +85.7% |
| Q3 2014 | $437,000 | +19.4% | 42,061 | +86.2% | 0.01% | +16.7% |
| Q2 2014 | $366,000 | -83.7% | 22,591 | -83.7% | 0.01% | -84.2% |
| Q1 2014 | $2,251,000 | -18.0% | 138,549 | -37.4% | 0.04% | -7.3% |
| Q4 2013 | $2,745,000 | +226.0% | 221,182 | +188.1% | 0.04% | +156.2% |
| Q3 2013 | $842,000 | -30.7% | 76,785 | -48.9% | 0.02% | -46.7% |
| Q2 2013 | $1,215,000 | – | 150,320 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |